Re-treatment versus extended treatment strategy of systemic bevacizumab in hereditary hemorrhagic telangiectasia: which is better?
作者信息
Epperla Narendranath, Kleman Ariel, Karafin Matthew, Foy Patrick
机构信息
Division of Hematology, The Ohio State University, 320W 10th Ave, Columbus, OH, 43210, USA.
Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI, USA.
出版信息
Ann Hematol. 2018 Sep;97(9):1727-1729. doi: 10.1007/s00277-018-3324-7. Epub 2018 Apr 14.
PMID:29656313
Abstract
摘要
Zotero 插件